Crossing scales to predict and prevent bat virus zoonoses in a Madagascar ecosystem
Project Number5DP2AI171120-03
Contact PI/Project LeaderBROOK, CARA
Awardee OrganizationUNIVERSITY OF CHICAGO
Description
Abstract Text
The wide-reaching impacts of the COVID-19 pandemic highlight the extreme threat posed by the cross-species
emergence of zoonotic pathogens. Bats (order: Chiroptera) are the natural reservoir hosts for the majority of
the world’s most virulent zoonotic viruses, including Hendra and Nipah henipaviruses, Ebola and Marburg
filoviruses, and SARS, MERS, and now SARS-CoV-2 coronaviruses. Remarkably, bats exhibit little
demonstrable disease upon infection with viruses that cause extreme pathology in other mammals, likely in
part due to their unique anti-inflammatory molecular adaptations, which are thought to have evolved to mitigate
the accumulation of physiological damage accrued during flight. Surprisingly, isolated island bat communities
around the world support the endemic circulation of numerous viruses in populations below the critical
community size required for persistence of related pathogens in other hosts. Since cross-species spillover of
several bat-borne viruses bears a distinctive seasonal signature, coincident with the timing of reproductive and
nutritional stress for the bat hosts in question, disentangling the mechanisms governing the transmission,
circulation, and persistence of these viruses in wild bat populations is of critical public health interest. In part
with the research initiatives proposed here, we will use molecular and serological tools to develop a
longitudinal time series of immunological and infection data for henipaviruses and coronaviruses circulating in
wild fruit bats in Madagascar, leveraging samples collected in our longterm wildlife surveillance effort. Bats are
widely consumed as a source of human food in Madagascar, and preliminary data from our research group
demonstrates serological signatures of prior human exposure to these zoonotic viruses across the island. We
propose to fit disparate dynamical models to the resulting population-level data in order to distinguish
mechanisms underpinning seasonal viral shedding pulses and concomitant transmission in these bat hosts. In
addition to population-level studies, we will also construct within-host models of viral control in a single bat
immune system, which we will fit to experimental infection data from Betacoronavirus-challenged bats in the
laboratory, with the aim of deciphering the mechanisms which motivate viral shedding. Our project aims to
simultaneously develop molecular tools of bat cell lines and viruses with which to support within-host studies in
our own Madagascar system. Finally, we will build on population-level and within-host studies to model and
implement a vaccine intervention designed to eradicate circulating henipavirus from a test-population of
Madagascar fruit bats. Broadly, our project aims to use a uniquely integrative combination of field, molecular,
and modeling tools to enable the prediction and prevention of bat virus spillover events before they occur.
Public Health Relevance Statement
The cross-species emergence of SARS-CoV-2 from wild, Rhinolophus spp. bats to human hosts highlights the
extreme public health, economic, and societal consequences that can result from zoonotic spillover. This
proposal leverages tools from mathematical modeling, field biology, and molecular immunology to decipher the
mechanisms underpinning the circulation of bat-borne viruses at a population-level, understand the processes
which shape their pathology within-host, and eradicate them from reservoir populations to prevent future
threats of zoonotic emergence.
NIH Spending Category
No NIH Spending Category available.
Project Terms
2019-nCoVAddressAfricanAnimalsAnti-Inflammatory AgentsBiologyCOVID-19 pandemic effectsCanis familiarisCase Fatality RatesCell LineChicagoChiropteraCirculationClinicalCollaborationsCommunicable DiseasesCommunitiesConsumptionCoronavirusCoupledDataDisciplineDiseaseDisparateDoctor of PhilosophyEbolaEcologyEconomicsEcosystemEvolutionExhibitsExposure toFilovirusFoodFruitFutureGoalsHendra VirusHenipavirusHenipavirus InfectionsHumanImmuneImmune systemImmunityImmunologicsInfectionInfection ControlInnate Immune ResponseInterventionIslandJamaicanLaboratoriesLearningLinkLiteratureMadagascarMammalsMarburgvirusMeaslesMiddle East Respiratory SyndromeMiddle East Respiratory Syndrome CoronavirusModelingMolecularMolecular ImmunologyMonitorNatureNipah VirusNutritionalParamyxovirusPathologyPatternPeriodicalsPhysiologic pulsePhysiologicalPhysiologyPopulationPopulation SizesPopulation StudyPostdoctoral FellowPreventionProcessPublic HealthRabies virusRecommendationRecrudescencesRegimenResearchResourcesSamplingSeasonal VariationsSeasonsSeriesSerologySevere Acute Respiratory SyndromeShapesSourceStressSystemTechniquesTestingTimeUnited States National Institutes of HealthUniversitiesVaccinatedVaccinationVaccinesViralViral Load resultVirulentVirusVirus DiseasesVirus SheddingWorkZoonosesantiviral immunitybat-bornebetacoronaviruschronic infectioncost effectivecross-species transmissiondesignexperienceexposed human populationfield studyimmunopathologyinfectious disease modelinnovationinterestmathematical modelnovelpandemic preparednesspathogenpost-doctoral trainingpreventprofessorreproductiveskillsspillover eventstressortherapy designtooltransmission processvaccine distributionviral transmissionwillingnesszoonotic spillover
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
005421136
UEI
ZUE9HKT2CLC9
Project Start Date
05-September-2022
Project End Date
31-August-2027
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$451,808
Direct Costs
$300,000
Indirect Costs
$151,808
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$451,808
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5DP2AI171120-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5DP2AI171120-03
Patents
No Patents information available for 5DP2AI171120-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5DP2AI171120-03
Clinical Studies
No Clinical Studies information available for 5DP2AI171120-03
News and More
Related News Releases
No news release information available for 5DP2AI171120-03
History
No Historical information available for 5DP2AI171120-03
Similar Projects
No Similar Projects information available for 5DP2AI171120-03